Natera, Inc. (NTRA)
341.87
+12.94
(+3.93%)
USD |
NASDAQ |
Sep 14, 16:00
342.00
+0.13
(+0.04%)
After-Hours: 17:49
Natera Enterprise Value : 46.39B for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 46.39B |
| September 10, 2026 | 45.98B |
| September 09, 2026 | 46.58B |
| September 08, 2026 | 45.70B |
| September 04, 2026 | 46.28B |
| September 03, 2026 | 46.20B |
| September 02, 2026 | 45.84B |
| September 01, 2026 | 45.21B |
| August 31, 2026 | 45.38B |
| August 28, 2026 | 46.00B |
| August 27, 2026 | 47.79B |
| August 26, 2026 | 47.75B |
| August 25, 2026 | 47.50B |
| August 24, 2026 | 46.21B |
| August 21, 2026 | 46.83B |
| August 20, 2026 | 45.80B |
| August 19, 2026 | 45.83B |
| August 18, 2026 | 43.91B |
| August 17, 2026 | 44.27B |
| August 14, 2026 | 43.66B |
| August 13, 2026 | 43.78B |
| August 12, 2026 | 44.52B |
| August 11, 2026 | 44.06B |
| August 10, 2026 | 44.87B |
| August 07, 2026 | 45.40B |
| Date | Value |
|---|---|
| August 06, 2026 | 37.26B |
| August 05, 2026 | 38.59B |
| August 04, 2026 | 38.67B |
| August 03, 2026 | 37.97B |
| July 31, 2026 | 37.60B |
| July 30, 2026 | 37.87B |
| July 29, 2026 | 35.60B |
| July 28, 2026 | 35.37B |
| July 27, 2026 | 36.20B |
| July 24, 2026 | 36.77B |
| July 23, 2026 | 37.16B |
| July 22, 2026 | 37.09B |
| July 21, 2026 | 37.52B |
| July 20, 2026 | 36.86B |
| July 17, 2026 | 38.12B |
| July 16, 2026 | 37.90B |
| July 15, 2026 | 38.98B |
| July 14, 2026 | 38.30B |
| July 13, 2026 | 38.34B |
| July 10, 2026 | 37.92B |
| July 09, 2026 | 39.62B |
| July 08, 2026 | 38.55B |
| July 07, 2026 | 39.54B |
| July 06, 2026 | 39.90B |
| July 02, 2026 | 39.26B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Guardant Health, Inc. | 21.67B |
| CareDx, Inc. | 2.233B |
| Myriad Genetics, Inc. | 422.25M |
| BioRestorative Therapies, Inc. | -0.1562M |
| Exagen, Inc. | 173.15M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -66.97M |
| Revenue (Quarterly) | 752.75M |
| Total Expenses (Quarterly) | 819.72M |
| EPS Diluted (Quarterly) | -0.4674 |
| Gross Profit Margin (Quarterly) | 63.70% |
| Profit Margin (Quarterly) | -8.90% |
| Earnings Yield | -0.40% |
| Normalized Earnings Yield | -0.3946 |